Sakshi Agarwal

About

Tuberculosis Infectious Disease Postdoc Scholar at A*star Sg

Employment

• A*star Infectious disease labs Scientist
  2023 - Present
• UCSF Medical Center Postdoctoral Scholar
  2020 - 2022

Education

• Translational Health Science and Technology Institute PhD
  2014 - 2019

Projects & Funding

Projects & funding information is unavailable.

Publications (5)

• The repurposed STAT3 inhibitor pyrimethamine controls mycobacterial infection-induced vascular permeability and mycobacterial burden.
  Darryl JY Han, Xiangyu Sui, Sakshi Agarwal +4 more
  Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2025 DOI: 10.1016/j.biopha.2025.118464
  +Save
• Navigating a Path to Rifampicin Resistance in Tuberculosis.
  mBio 2023 DOI: 10.1128/mbio.02952-22
  +Save
• VapC21 Toxin Contributes to Drug-Tolerance and Interacts With Non-cognate VapB32 Antitoxin in Mycobacterium tuberculosis.
  Arun Sharma, Gopinath Chattopadhyay, Pankaj Chopra +7 more
  Frontiers in microbiology 2020 DOI: 10.3389/fmicb.2020.02037
  +Save
• VapBC22 toxin-antitoxin system from Mycobacterium tuberculosis is required for pathogenesis and modulation of host immune response.
  Sakshi Agarwal, Arun Sharma, Rania Bouzeyen +10 more
  Science advances 2020 DOI: 10.1126/sciadv.aba6944
  +Save
• Structural, functional and biological insights into the role of Mycobacterium tuberculosis VapBC11 toxin-antitoxin system: targeting a tRNase to tackle mycobacterial adaptation.
  Amar Deep, Prabhakar Tiwari, Sakshi Agarwal +4 more
  Nucleic acids research 2018 DOI: 10.1093/nar/gky924
  +Save